Massimo Tommasino (France)

International Agency for Research on Cancer (IARC) Infections and Cancer Biology group

Research and Professional Experience 11/2012 – Head of Section of Infections, International Agency for Research on Cancer, World Health Organization, Lyon, France. 05/2002 – Head of the “Infections and Cancer Biology Group”, International Agency for Research on Cancer, World Health Organization. Lyon, France. 1995 –2002 Group Leader, German Cancer Research Centre (DKFZ). Heidelberg, Germany. 1991 –1995 Research Fellow, Imperial Cancer Research Fund, “Tumour Virus Group”. Cambridge, United Kingdom. 1986 –1991 Researcher at the Sclavo Research Centre. Siena, Italy. 1985 –1986 Researcher at the Department of Biochemistry, University of Bari, Italy. 1984 –1985 Post-doctoral Fellow, Department of Molecular Biology, University of Oregon. Eugene, USA. 1981 –1983 Post-doctoral Fellow, Department of Biochemistry, University of Bari, Italy. Member of the Editorial Board of Scientific Journals Journal of General Virology (1995–2000), Papillomavirus Today (2003–present), Virology (2013–present), Molecular and Cellular Oncology (2014–present). Reviewing activities Reviewer on a regular basis for Journal of Virology, Virology, Journal of General Virology, Oncogene, International Journal of Cancer, PLoS Pathogens. Reviewer for grant applications from different National and International organisations, e.g Italian Association for Cancer Research, Association for International Cancer Research, UICC, Medical Research Council, Cancer Research UK, Association pour la Recherche sur le Cancer, The Wellcome Trust Belgian Foundation against Cancer, Agence Nationale de la Recherche. External Fundings Support by the European Union FP6 and FP7, Krebshilfe, the Association for International Cancer Research (AICR), Association pour la Recherche sur le Cancer (ARC), Ligues Régionales contre le Cancer (https://www.ncbi.nlm.nih.gov/pubmed/?term=tommasino+m) Publications More than 300 scientific articles (h-index: 50) in peer-reviewed journals, e.g. Oncogene, International Journal of Cancer, Virology, Journal of Virology, EMBO Report, FASEB Journal, Molecular and Cellular Biology, PNAS, PLoS Pathogens, Lancet, Lancet Oncology. Others National Italian habilitation for full professor in (i) Molecular Biology; (ii) Microbiology and (iii) Clinical Microbiology

Presenter of 1 Presentation

Conference Calendar

Workshop 2: HPV Genera and Associated Diseases Hall D

Beta HPV Beta Genus Papillomaviruses and HPV-associated diseases (ID 70)

Session Date

07/20/2020

Session Time

11:00 - 12:35

Room

Hall D

Session Type

Basic Science

Session Name

Workshop 2: HPV Genera and Associated Diseases

Lecture Time

11:53 - 12:13

Presenter

Massimo Tommasino (France)

Authors

Massimo Tommasino (France)

Moderator of 1 Session

Conference Calendar

Basic Science Oral Session

00810 - Oral Session 5: Other Anatomical Sites and Diseases (ID 26)

Session Type

Basic Science Oral Session

Session Date

07/23/2020

Session Time

07:15 - 08:30

Room

Hall D

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"ATOMIC RESOLUTION CRYOEM STRUCTURE OF MOUSE PAPILLOMAVIRUS \u003Csmall\u003E(ID 815)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":815,"presentation":"ATOMIC RESOLUTION CRYOEM STRUCTURE OF MOUSE PAPILLOMAVIRUS \u003Csmall\u003E(ID 815)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Samantha R. Hartmann (United States of America)","photo":""},"playlist":[{"name":"ATOMIC RESOLUTION CRYOEM STRUCTURE OF MOUSE PAPILLOMAVIRUS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/815 Samantha Hartmann.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/815 Samantha Hartmann.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/2F458AA1.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/815 Samantha Hartmann.vtt"}]},{"name":"TRANSLATIONAL STUDIES OF PEDIATRIC RESPIRATORY PAPILLOMATOSIS \u003Csmall\u003E(ID 608)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":608,"presentation":"TRANSLATIONAL STUDIES OF PEDIATRIC RESPIRATORY PAPILLOMATOSIS \u003Csmall\u003E(ID 608)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Susanne Wells (United States of America)","photo":""},"playlist":[{"name":"TRANSLATIONAL STUDIES OF PEDIATRIC RESPIRATORY PAPILLOMATOSIS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200708-125945_Susanne-We_1760x900-0.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200708-125945_Susanne-We_1760x900-0.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/D43DF196.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200708-125945_Susanne-We_1760x900-0.vtt"}]},{"name":"VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS \u003Csmall\u003E(ID 1357)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1357,"presentation":"VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS \u003Csmall\u003E(ID 1357)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Laura Asensio Puig (Spain)","photo":""},"playlist":[{"name":"VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Laura Asensio Puig - IPVC20 - 1357 - VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/Laura Asensio Puig - IPVC20 - 1357 - VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/A44D4F17.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Laura Asensio Puig - IPVC20 - 1357 - VIRAL GENOME VARIATION IN VULVAR HPV16- ASSOCIATED HIGH GRADE PRECANCER LESIONS AND INVASIVE CANCERS.vtt"}]},{"name":"HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES \u003Csmall\u003E(ID 377)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":377,"presentation":"HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES \u003Csmall\u003E(ID 377)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Tarik Gheit (France)","photo":""},"playlist":[{"name":"HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Tarik Gheit IPVC 20 377 HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/Tarik Gheit IPVC 20 377 HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/E86EA0B7.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/Tarik Gheit IPVC 20 377 HPV DISTRIBUTION IN DIFFERENT ANATOMICAL SITES.vtt"}]},{"name":"BETA- AND GAMMA-HPV INFECTIONS IN ASSOCIATION WITH INCIDENT CUTANEOUS SQUAMOUS CELL CARCINOMA: A PROPSECTIVE COHORT STUDY \u003Csmall\u003E(ID 946)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":946,"presentation":"BETA- AND GAMMA-HPV INFECTIONS IN ASSOCIATION WITH INCIDENT CUTANEOUS SQUAMOUS CELL CARCINOMA: A PROPSECTIVE COHORT STUDY \u003Csmall\u003E(ID 946)\u003C\/small\u003E","session":"Oral Session 5: Other Anatomical Sites and Diseases","presenter":"Dana ROLLISON (United States of America)","photo":""},"playlist":[{"name":"BETA- AND GAMMA-HPV INFECTIONS IN ASSOCIATION WITH INCIDENT CUTANEOUS SQUAMOUS CELL CARCINOMA: A PRO","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200615-134614_Dana-E--Ro_1920x1200.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200615-134614_Dana-E--Ro_1920x1200.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/26966E62.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/26\/GMT20200615-134614_Dana-E--Ro_1920x1200.vtt"}]}]